Artivion | CRY - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Abbott USD 2.39B 27M 2026-03
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 394K 1.97M 2026-03
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Inogen USD -6.06M 467K 2024-09
Integra LifeSciences USD -2.41M 6.72M 2026-03
J&J USD 7.82B 2.86B 2026-03
Mesa Laboratories USD -2.22M 6.03M 2024-12
Orthofix International USD -2.19M 20.07M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
ResMed USD 496.15M 13.77M 2025-12
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD 4.68M 29.82M 2025-12
Teleflex USD 218.94M 657.52M 2025-12
Terumo JPY 31.67B 13.71B 2026-03
Trinity Biotech USD -5.06M 10.74M 2025-09